Wed, November 17, 2021

Tejas Savant Downgraded (BDSX) to Hold and Decreased Target to $11 on, Nov 17th, 2021

Tejas Savant of Morgan Stanley, Downgraded "Biodesix, Inc." (BDSX) to Hold and Decreased Target from $21 to $11 on, Nov 17th, 2021.

Tejas, nor any peers, have made any analyst calls on BDSX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30